Politico newsletter features letter on COVID-19 diagnostics signed by GHTC director
A letter endorsed by GHTC's director Jamie Bay Nishi calling for greater investment in research on COVID-19 diagnostics through the ACT Accelerator was featured in Politico Europe's Morning Health Care newsletter. The letter, from the G20 Health and Development Partnership, notes the ACT Accelerator has allocated only 2.5 percent of funding to diagnostics despite their critical importance to an effective response to COVID-19 and calls for countries to remedy this funding imbalance at the June 27th Second Pledging Conference organized by the European Union in partnership with Global Citizen.
See excerpt below from the Politico newsletter:
FIRST IN MHC — ‘MORE MONEY FOR TESTING,’ ADVOCACY GROUP SAYS: The G20 Health and Development Partnership is calling for more funds to be spent on testing. In an open letter due to be published today, the advocacy group said that too little money is being spent on diagnostic solutions in the pandemic. It noted that the ACT-Accelerator has allocated about 46 percent of donated funds to strengthen health systems and around 24 percent to vaccine development, but less than 3 percent on testing solutions. “It is puzzling why diagnostics have received such low levels of funding given its critical importance to an effective response to COVID-19,” the letter reads.